Rasagiline Tablets 1 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily, either as monotherapy or as adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose in patients taking levodopa is 0.5mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.

This medicine should not be used by individuals who are allergic to the active ingredient or other components of this medication. Additionally, it should not be administered to those who are taking other MAO inhibitors or have discontinued them within the last 2 weeks. This medication should also not be used if you are taking specific medications such as pethidine, tramadol, or dextromethorphan, or have stopped taking them within the last 2 weeks. Patients with moderate to severe liver dysfunction should not take this medicine, and caution is advised for those with mild liver impairment. This medicine can cause various side effects, with headaches, dizziness, nausea, insomnia, dermatitis, musculoskeletal pain, hallucinations, and depression being commonly reported. During treatment with this medication, potential skin cancers such as melanoma should be regularly monitored, and any suspected skin changes should be discussed with a specialist. Caution is needed while driving or operating machinery as drowsiness or sudden sleep may occur; avoid hazardous activities if these symptoms arise. Severe side effects may occur when this medication is combined with other drugs, especially antidepressants, sympathomimetics, and certain analgesics, so consultation with a doctor or pharmacist is essential. There is insufficient data on the safety of this medication during pregnancy or breastfeeding, so it should be used with caution in these circumstances. This medication is not used in children as safety and efficacy have not been established. In case of overdose, severe hypertension or neurological disturbances may occur, requiring immediate medical assistance; there is no specific antidote, so appropriate treatment should be provided based on symptoms. This medicine should be stored at temperatures between 1°C and 25°C, in a secure place out of reach of children.

• influenza
• skin cancer
• leukopenia
• allergy
• appetite loss
• depression
• hallucination
• headache
• cerebrovascular accident
• conjunctivitis

This medicine must be stored in a tightly closed container to protect it from air and moisture, preferably in a cool place between 1°C and 25°C. Storing it this way helps to maintain its effectiveness and prevent deterioration.

Appearance

White round tablets

Package unit

30 tablets/box [(10 tablets/PTP*3)]